Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.52 |
| ▸ | APLNR | P35414 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.37 |
| ▸ | GRM4 | Q14833 | 6/20 | 0.36 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.36 |
| ▸ | GRM3 | Q14832 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | GRM8 | O00222 | 2/20 | 0.36 |
| ▸ | GRM6 | O15303 | 2/20 | 0.36 |
| ▸ | GRM5 | P41594 | 1/20 | 0.36 |
| ▸ | MTOR | P42345 | 1/20 | 0.36 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.36 |
| ▸ | PLCB1 | Q9NQ66 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15514216 | 0.80 | SLC6A4 (0.55) | SLC6A4APLNRALDH1A1CYP1A2ALOX15 | |
| SCHEMBL8895480 | 0.75 | SLC6A4 (0.53) | SLC6A4APLNRALDH1A1CYP1A2ALOX15 | |
| SCHEMBL4755338 | 0.71 | SLC6A4 (0.59) | SLC6A4APLNRALDH1A1CYP1A2ALOX15 | |
| SCHEMBL8002117 | 0.70 | SLC6A4 (0.49) | SLC6A4APLNRALDH1A1CYP1A2ALOX15 | |
| Camphoric Acid SCHEMBL12308 | 0.69 | ALDH1A1 (0.66) | ALDH1A1CYP1A2ALOX15CYP2C19GRM4 | |
| Camphoric Acid SCHEMBL1738809 | 0.69 | ALDH1A1 (0.66) | ALDH1A1CYP1A2ALOX15CYP2C19GRM4 | |
| Camphoric Acid SCHEMBL7099871 | 0.69 | ALDH1A1 (0.66) | ALDH1A1CYP1A2ALOX15CYP2C19GRM4 | |
| Camphoric Acid SCHEMBL52395 | 0.69 | ALDH1A1 (0.66) | ALDH1A1CYP1A2ALOX15CYP2C19GRM4 | |
| Camphoric Acid SCHEMBL2513165 | 0.69 | ALDH1A1 (0.66) | ALDH1A1CYP1A2ALOX15CYP2C19GRM4 | |
| Camphoric Acid SCHEMBL23643 | 0.69 | ALDH1A1 (0.66) | ALDH1A1CYP1A2ALOX15CYP2C19GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113274506-A | Drug delivery technology of polymer-carbohydrate conjugates | 念·吴 | 2021-08-20 | — | — | CN | claimed |
| EP-3077006-B1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | WU NIAN (US) | 2020-08-19 | — | — | EP | claimed |
| EP-3313857-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | Wu, Nian (US) | 2018-05-02 | — | — | EP | claimed |
| US-20160375150-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | LIPOSEUTICALS INC | 2016-12-29 | — | — | US | claimed |
| WO-2016209732-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | WU NIAN (US) | 2016-12-29 | — | — | WO | claimed |
| EP-3077006-A1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | Wu, Nian (US) | 2016-10-12 | — | — | EP | claimed |
| WO-2015085173-A1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | WU NIAN (US) | 2015-06-11 | — | — | WO | claimed |
| US-20150157721-A1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | LIPOSEUTICALS INC | 2015-06-11 | — | — | US | claimed |
| CN-104704023-A | Polymer-carbohydrate-lipid conjugates | WU NIAN | 2015-06-10 | — | — | CN | claimed |
| EP-2673000-A2 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | Wu, Nian (US) | 2013-12-18 | — | — | EP | claimed |
| WO-2012109112-A2 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-16 | — | — | WO | claimed |
| WO-2012109052-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2012-08-16 | — | — | WO | claimed |
| US-20120202979-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPOSEUTICALS, INC. | 2012-08-09 | — | — | US | claimed |
| WO-2011069746-A1 | REACTIVE COMPOUNDS ON THE BASIS OF TRANSESTERIFICATION | EVONIK DEGUSSA GMBH (DE) | 2011-06-16 | — | — | WO | claimed |
| EP-0861264-A2 | COLLAGEN-LIKE PEPTOID RESIDUE-CONTAINING STRUCTURES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-09-02 | — | — | EP | claimed |
| WO-1997019106-A2 | COLLAGEN-LIKE PEPTOID RESIDUE-CONTAINING STRUCTURES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-05-29 | — | — | WO | claimed |
| WO-2025137256-A1 | POLYOXAZOLINE-CARBOHYDRATE-LIPID CONJUGATES | WU NIAN (US) | 2025-06-26 | — | — | WO | disclosed |
| CN-117836596-A | Temperature indicator manufacturing system and temperature indicator manufacturing method | 株式会社日立产机系统 | 2024-04-05 | — | — | CN | disclosed |
| WO-2011069746-A1 | REACTIVE COMPOUNDS ON THE BASIS OF TRANSESTERIFICATION | EVONIK DEGUSSA GMBH (DE) | 2011-06-16 | — | — | WO | disclosed |
| CN-101883773-A | Polyketal compounds, synthesis, and applications | SEGETIS INC | 2010-11-10 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150157721-A1 | POLYMER-CARBOHYDRATE CONJUGATES FOR DRUG DELIVERY TECHNOLOGY | LIPC, FABP4, CETP | SLC6A4 1255/4885APLNR 1702/4885ALDH1A1 2457/4885 |
| US-20120202979-A1 | POLYMER-CARBOHYDRATE-LIPID CONJUGATES | LIPC, FUT6, UGCG | SLC6A4 2643/4885APLNR 937/4885ALDH1A1 873/4885 |
| US-20160375150-A1 | POLYMER-CYCLODEXTRIN-LIPID CONJUGATES | CETP, FADS2, FABP4 | SLC6A4 1383/4885APLNR 3975/4885ALDH1A1 1355/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.